Hosted on MSN11h
Wedbush Initiates Coverage of Bicara Therapeutics (BCAX) with Outperform RecommendationFintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...
Wedbush analyst Nick Setyan upgraded Denny’s (DENN) to Outperform from Neutral with a price target of $10, up from $6. First, the firm believes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback